年轻癌症幸存者卵巢储备指标随生殖寿命的变化速率差异
该前瞻性队列研究比较了170例年轻癌症幸存者、135例同龄对照和71例晚生殖龄对照的卵巢储备指标(MOR)年变化率。调整BMI、治疗结束时间和外源激素使用后,幸存者AMH和AFC几何均值在各年龄均低于同龄对照;24.5岁后两组AMH和AFC下降速率相似(AMH P=0.78,AFC P=0.37)。晚生殖龄对照AMH年降30%、AFC年降16%,显著快于幸存者(P<0.01)。
要点
- 年轻癌症幸存者AMH和AFC水平在各年龄均低于同龄对照。
- 24.5岁后幸存者与同龄对照的AMH和AFC下降速率无显著差异。
- 晚生殖龄对照AMH年降30%、AFC年降16%,下降更陡峭。
核心结论
- 幸存者入组时AMH和AFC水平较低,但AMH和AFC的变化速率与同龄对照无显著差异。
研究设计与样本
- 前瞻性队列研究,纳入170例癌症幸存者、135例同龄对照和71例晚生殖龄对照,每年随访行早卵泡期激素分析和超声。
主要发现
- 幸存者和同龄对照平均随访38个月,晚生殖龄对照平均随访24个月。
- 调整BMI、幸存者治疗结束时间和外源激素使用后,幸存者AMH和AFC几何均值在各年龄均低于同龄对照。
- 24.5岁后两组AMH和AFC下降速率相似(AMH P=0.78,AFC P=0.37)。
- 晚生殖龄对照AMH年降30%、AFC年降16%,与幸存者相比P<0.01。
关键数值与推荐
- 24.5岁后幸存者与同龄对照AMH下降速率比较P=0.78,AFC下降速率比较P=0.37。
- 晚生殖龄对照AMH年降30%、AFC年降16%,与幸存者比较P<0.01。
临床怎么用
- 年轻癌症幸存者AMH和AFC水平较低,但下降速率与同龄对照相似,可据此咨询卵巢储备变化趋势。
- 晚生殖龄女性AMH和AFC下降更陡峭,需关注其生殖衰老速度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Recent studies have examined level and rate of change of anti-Müllerian hormone (AMH) for predicting time to menopause. Limited prospective, longitudinal data exists evaluating measures of ovarian reserve (MOR) in cancer survivors. PURPOSE: Determine the rate of change of MOR in survivors (15 to 39 years) compared with similar-aged controls and compared with late reproductive-aged controls (40 to 50 years). DESIGN: Prospective cohort. SETTING: Quaternary university hospital. PARTICIPANTS: Survivors at least 1 year from therapy completion, similar-aged controls, and late reproductive-aged controls. INTERVENTIONS: Annual visits with early follicular-phase hormone analysis and ultrasound. MAIN OUTCOME MEASURE: Changes in AMH and antral follicle count (AFC) were modeled using random effects linear regression. RESULTS: Cancer survivors (170) and 135 similar-aged controls had annual visits for an average of 38 months; 71 late reproductive-aged controls were followed for an average of 24 months. In models adjusted for body mass index, time since cancer therapy (for survivors), and exogenous hormone use, the geometric mean AMH and AFC levels were lower in the survivors than similar-aged controls at all ages. After age 24.5 AMH and AFC declined in both groups at rates that were similar (P = 0.78 for AMH, P = 0.37 for AFC). Late reproductive-aged controls declined at a much more precipitous rate of 30% per year for AMH and 16% per year for AFC (P < 0.01 compared with survivors). CONCLUSIONS: Although survivors had lower levels of AMH and AFC at the time of enrollment, the rate of change of AMH and AFC is not significantly different than similar-aged controls.
引用
- Cameron K, Sammel MD, Prewitt M, et al. Differential Rates of Change in Measures of Ovarian Reserve in Young Cancer Survivors Across the Reproductive Lifespan. J Clin Endocrinol Metab. 2019. PMID: 30566616. doi:10.1210/jc.2018-02257
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。